Polygenic modelling of treatment effect heterogeneity
Zhi Ming Xu, Stephen Burgess
doi: https://doi.org/10.1101/2020.01.06.20016618
Zhi Ming Xu
1MRC Biostatistics Unit, Cambridge, UK
2School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
Stephen Burgess
1MRC Biostatistics Unit, Cambridge, UK
3Department of Public Health and Primary Care, University of Cambridge, UK
Data Availability
The data that support the findings of this study are available on application to any bona fide researcher. See https://www.ukbiobank.ac.uk/ for more details.
Posted January 10, 2020.
Polygenic modelling of treatment effect heterogeneity
Zhi Ming Xu, Stephen Burgess
medRxiv 2020.01.06.20016618; doi: https://doi.org/10.1101/2020.01.06.20016618
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2300)
- Dermatology (205)
- Emergency Medicine (372)
- Epidemiology (11633)
- Forensic Medicine (10)
- Gastroenterology (685)
- Genetic and Genomic Medicine (3638)
- Geriatric Medicine (342)
- Health Economics (624)
- Health Informatics (2335)
- Health Policy (921)
- Hematology (336)
- HIV/AIDS (761)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3393)
- Nursing (193)
- Nutrition (512)
- Oncology (1783)
- Ophthalmology (527)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6031)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (144)